Risk of febrile seizures after first dose of measles-mumps-rubella- varicella vaccine: A population-based cohort study

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 11, 2014, Pages 824-829

  MacDonald, Shannon E ^a,c   Dover, Douglas C ^d   Simmonds, Kimberley A ^b,d   Svenson, Lawrence W ^b,c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Alberta Ministry of Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; PRIORIX-TETRA; UNCLASSIFIED DRUG;

ARTICLE; CANADA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEBRILE CONVULSION; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; VACCINATION;

ALBERTA; CHICKENPOX VACCINE; COHORT STUDIES; HUMANS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEIZURES, FEBRILE; VACCINES, COMBINED;

EID: 84905454590     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.140078     Document Type: Article

References (37)

1. Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2013 to 31 July 2013. Off J Eur Union 2013;56(C250):30-43.
2. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010;126:e1-8.
3. Klein NP, Lewis E, Baxter R, et al. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics 2012;129:809-14.
4. Statement on measles-mumps-rubella-varicella vaccine. Can Commun Dis Rep 2010;36(ACS-9):1-22.
5. Routine immunization schedule. Edmonton (AB): Alberta Health; 2013. Available: www.health.alberta.ca/health-info/imm-routine-schedule.html (accessed 2013 Dec. 20).
6. Czajka H, Schuster V, Zepp F, et al. A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile. Vaccine 2009;27:6504-11.
7. Schink T, Holstiege J, Kowalzik F, et al. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine 2014;32:645-50.
8. Hviid A. Measles-mumps-rubella-varicella combination vaccine increases risk of febrile seizure. J Pediatr 2011;158:170.
9. Interactive Health Data Application. Edmonton (AB): Alberta Health; 2013. Available: www.ahw.gov.ab.ca/IHDA-Retrieval/ (accessed 2014 Jan. 6)
10. Russell ML, Schopflocher DP, Svenson L, et al. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007;135:908-13. (Pubitemid 47616471)
11. Quan H, Khan N, Hemmelgarn BR, et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009;54:1423-8.
12. Chen G, Khan N, Walker R, et al. Validating ICD coding algorithms for diabetes mellitus from administrative data. Diabetes Res Clin Pract 2010;89:189-95.
13. Reid AY, St Germaine-Smith C, Liu M, et al. Development and validation of a case definition for epilepsy for use with administrative health data. Epilepsy Res 2012;102:173-9.
14. Jetté N, Reid AY, Quan H, et al. How accurate is ICD coding for epilepsy? Epilepsia 2010;51:62-9.
15. Lix LMW, Walker R, Quan H, et al. Features of physician services databases in Canada. Chronic Dis Inj Can 2012;32:186-93.
16. Quality assurance processes applied to the Discharge Abstract and Hospital Morbidity databases. Ottawa (ON): Canadian Institute of Health Information; 2008.
17. Quantin C, Benzenine E, Velten M, et al. Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology. Am J Epidemiol 2013;178:1731-9.
18. Hanf M, Quantin C, Farrington P, et al. Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization. Vaccine 2013;31:5856-62.
19. Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 2004;292:351-7. (Pubitemid 38944259)
20. Tse A, Tseng HF, Greene SK, et al. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine 2012;30:2024-31.
21. Product monograph: Priorix-Tetra. Combined measles, mumps, rubella and varicella vaccine, live, attenuated. Mississauga (ON): GlaxoSmithKline; 2013. Available: www.gsk.ca/english/docs-pdf/product-monographs/Priorix-tetra.pdf (accessed 2014 Jan. 6).
22. Rowhani-Rahbar A, Fireman B, Lewis E, et al. Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr 2013; 167:1111-7.
23. Glanz JM, McClure DL, Xu S, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol 2006;59:808-18. (Pubitemid 43996937)
24. Akaike H. Likelihood of a model and information criteria. J Econom 1981;16:3-14.
25. Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 2009;27:4656-61.
26. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59(RR-3):1-12.
27. Russell ML, Dover DC, Simmonds KA, et al. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine 2013 Oct. 4. [Epub ahead of print].
28. Donahue JG, Kieke BA, Yih K, et al. Varicella vaccination and ischemic stroke in children: Is there an association? Pediatrics 2009;123:e228.
29. Rowhani-Rahbar A, Klein NP, Dekker CL, et al. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine 2012;31:271-7.
30. Tseng HF, Sy LS, Liu I, et al. Postlicensure surveillance for prespecified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine 2013;31:2578-83.
31. Top KA, Constantinescu CM, Laflèche J, et al. Applicability of the Brighton Collaboration case definition for seizure after immunization in active and passive surveillance in Canada. Vaccine 2013;31:5700-5.
32. Mills E, Jadad AR, Ross C, et al. Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol 2005;58:1081-8. (Pubitemid 41441694)
33. Bardenheier B, Yusuf H, Schwartz B, et al. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children? Arch Pediatr Adolesc Med 2004;158:569-75. (Pubitemid 38720489)
34. MacDonald SE. Exploring the association between parental concern about vaccine safety and incomplete childhood immunization: a multivariate model [dissertation]. Edmonton (AB): University of Alberta; 2013.
35. Streng A, Liese JG. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella. Vaccine 2014;32:897-900.
36. Warden CR, Zibulewsky J, Mace S, et al. Evaluation and management of febrile seizures in the out-of-hospital and emergency department settings. Ann Emerg Med 2003;41:215-22.
37. von Spiczak S, Helbig I, Drechsel-Baeuerle U, et al. A retrospective population-based study on seizures related to childhood vaccination. Epilepsia 2011;52:1506-12.